ISBN 10: 1855734583 / ISBN 13: 9781855734586
Gebraucht / Anzahl: 0
Bei weiteren Verkäufern erhältlich
Alle  Exemplare dieses Buches anzeigen

Über dieses Buch

Leider ist dieses Exemplar nicht mehr verfügbar. Wir haben Ihnen weitere Exemplare dieses Titels unten aufgelistet.

Beschreibung:

This Book is in Good Condition. Clean Copy With Light Amount of Wear. 100% Guaranteed. Summary: This practical guide gives investors all the tools they need to assess the financial and business opportunities offered by the financial sector. This second edition of the respectedPharmaceutical Equities, has been revised and updated to reflect the changes, particularly in life sciences, since the first edition. All financial aspects of pharmaceutical companies, from chemical research to sales, are discussed in this essential reference work. Buchnummer des Verkäufers

Über diesen Titel:

Bewertung (bereitgestellt von Goodreads):
0 durchschnittlich
(0 Bewertungen)

Inhaltsangabe: The pharmaceutical sector offers some of the most exciting financial and business opportunities today. This essential and practical guide gives you all the tools you need to assess such opportunities. The second edition of the respected Pharmaceutical Equities, it has been thoroughly revised and updated to reflect the changes, especially in life sciences, since the first edition. The book is international in outlook, and explains the rules of the game not just for wise investing, but also for understanding how this uniquely complex and highly regulated business works. The authors explain:

  • HOW to evaluate the technology and research and development, as well as the sales potential of ensuing products
  • WHAT key issues will affect and influence companies in the next few years
  • HOW to balance potential high returns on breakthrough products against accompanying risks
The book begins with a look at the global pharmaceutical industry, from its history to the structure of present day companies. The second part explores how to analyse and value pharmaceutical and biotechnology companies. The final part deals with trading itself and looks at share price movement and the main equity markets throughout the world. Both practical and comprehensive, this handbook will be essential reading for investors, analysers and corporate planners - and is the ONLY book which will show you how to actually value pharmaceutical companies.

From the Publisher: Part 1: THE GLOBAL PHARMACEUTICAL INDUTRY Part 2: ANALYSIS AND EVALUATION OF PHARMACEUTICAL COMPANIES Part 3: PHARMACEUTICAL EQUITY TRADING Part 1: THE GLOBAL PHARMACEUTICAL INDUTRY

Pharmaceuticals and the treatment of disease - History - Biotechnology - Changing patterns of health - Drug discovery - Intellectual property - R&D - The use of pharmaceuticals

Structure and internationalisation of the industry - Pharmaceutical market structure - The global marketplace - International organisations - Mutual recognition agreements - Trade associations

Regional and national developments - The USA - The European single market - Japan - Emerging markets

Major changes in the pharmaceutical industry - Industry consolidation - Life sciences - Genomics - Generics - Drug delivery - Vaccines - Outsourcing - Distributors and wholesalers - DTC advertising - E-commerce Part 2: ANALYSIS AND EVALUATION OF PHARMACEUTICAL COMPANIES

Valuing major quoted companies - Factors in assessing pharmaceutical equities - Standard investment analysis criteria - Financial accounts - policies and analysis - Company strategy - Competition - Financial policy and non-operating income - Takeover bid and merger valuation - Comparative analysis

Valuing new venture and biotechnology companies - The US and European markets - Innovation in the pharmaceutical industry - Stages of development and funding requirements - Venture capital - New issues and initial public offerings - Evaluation of development companies - Equity trading and liquidity - Biotechnology companies

The assessment of research and development - R&D organisation and strategy - Early research - Important stages of development - Issues in R&D assessment - Interpretation of clinical trial results - Project failure - Comparative analysis and efficiency of R&D spend - Sources of information on R&D

The assessment of product sales performance - Changes in product sales expectations - Issues in pharmaceutical product forecasting - Size of market - Forecasting market growth - Estimating market share - Pricing and reimbursement - Product loyalty - Launch phasing - Company priorities - Salesforce - Blockbusters Part 3: PHARMACEUTICAL EQUITY TRADING

Key issues influencing pharmaceutical share price movement - General equity market price movements - Pharmaceutical sector price movements - Company price movements - Sources of price sensitive news - Chart analysis

Investment and trading strategy - Factors in portfolio selection - Timing and risk - International fund management - Use of options and derivatives

Dealing in major equity markets - USA - Europe - Japan

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Zustand: Used

Beste Suchergebnisse bei AbeBooks

1.

Porter, Andrew, Beynon, Karen
Verlag: Woodhead Publishing (2000)
ISBN 10: 1855734583 ISBN 13: 9781855734586
Gebraucht Hardcover Anzahl: 1
Anbieter
Dream Books Company, LLC
(Englewood, CO, USA)
Bewertung
[?]

Buchbeschreibung Woodhead Publishing, 2000. Hardcover. Buchzustand: Good. Used book with normal wear and tear and may contain writing. Stock photo may be different from actual book cover. Please feel free to contact us for additional photos or details about this item. International Customers: Items over 3 lbs may incur additional shipping charges. Buchnummer des Verkäufers mon0000842159

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Gebraucht kaufen
EUR 149,83
Währung umrechnen

In den Warenkorb

Versand: EUR 2,99
Innerhalb USA
Versandziele, Kosten & Dauer

2.

Karen Beynon
Verlag: Woodhead Pub Ltd (2000)
ISBN 10: 1855734583 ISBN 13: 9781855734586
Neu Hardcover Anzahl: 1
Anbieter
Revaluation Books
(Exeter, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Woodhead Pub Ltd, 2000. Hardcover. Buchzustand: Brand New. 2nd edition. 192 pages. 9.21x6.38x0.79 inches. In Stock. Buchnummer des Verkäufers zk1855734583

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 242,64
Währung umrechnen

In den Warenkorb

Versand: EUR 6,71
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

3.

Karen Beynon; Andrew Porter
Verlag: Woodhead Publishing (2000)
ISBN 10: 1855734583 ISBN 13: 9781855734586
Neu Hardcover Erstausgabe Anzahl: 1
Anbieter
Irish Booksellers
(Rumford, ME, USA)
Bewertung
[?]

Buchbeschreibung Woodhead Publishing, 2000. Hardcover. Buchzustand: New. book. Buchnummer des Verkäufers 1855734583

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 362,73
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb USA
Versandziele, Kosten & Dauer